Pension Fund

Updated:

Tate & Lyle UK Pension Plan

The Tate & Lyle UK Pension Plan serves the legacy UK workforce of Tate & Lyle PLC, the FTSE-listed sweetener and texturizer manufacturer born from Henry...

Tate & Lyle UK Pension Plan

The Tate & Lyle UK Pension Plan serves the legacy UK workforce of Tate & Lyle PLC, the FTSE-listed sweetener and texturizer manufacturer born from Henry Tate & Sons and Abram Lyle & Sons. The plan sponsors a defined-benefit promise that, by the late 2010s, represented a material balance-sheet exposure relative to the corporate parent's market capitalization. In 2019, under the financial stewardship of then-CFO Imran Nawaz, the scheme executed a full buy-in with Legal & General, effectively transferring longevity, interest-rate, and inflation risk to an insurance counterparty while maintaining the trustee board's fiduciary oversight. Current CFO Sarah Kuijlaars, appointed in September 2024, now oversees the corporate side of this relationship alongside CEO Nick Hampton. The 2019 buy-in reshaped the plan's investment strategy fundamentally. Where once the scheme likely held diversified growth assets — equities, credit, property, perhaps alternatives — the majority of its capital now sits within an insurer-managed bulk annuity policy. This structure overlays a portfolio of highly rated fixed-income instruments and liability-matching gilts onto the plan's obligations. The residual self-managed allocation, if any, is expected to be modest and short-duration, held mainly for fee liquidity and final administrative expenses as the plan hibernates toward eventual buyout and transfer to the insurer's books. The geographic focus remains the United Kingdom, consistent with the scheme's statutory home and sterling-denominated liabilities. The scheme's trustee board, chaired by Michael Chatterton, coordinates with current CFO Sarah Kuijlaars — appointed in September 2024 — on residual governance matters including actuarial valuations, member communications, and the long-term path to buyout. No dedicated in-house investment team is publicly visible, typical of a pension plan in wind-down mode. The board draws on external consultants and the insurer's ongoing service framework. The plan maintains membership in the Pensions and Lifetime Savings Association, connecting it to industry practice and regulatory dialogue as it navigates its final years as a standalone entity. What distinguishes the Tate & Lyle Plan structurally from active UK corporate pension schemes is the completeness of its derisking. By executing a full buy-in in 2019 rather than staging partial transactions over a decade, the trustees compressed the typical UK pension endgame by years, eliminating sponsor covenant volatility in one move. This positions the plan less as an allocator evaluating new opportunities and more as a supervised insurance contract — a pattern that an increasing number of mid-sized UK defined-benefit schemes are following as buy-in pricing becomes competitive and regulatory pressure to derisk intensifies.

General information

Firm type

Pension Fund

Year founded

AUM

Approximately £2.2B–£2.5B in assets (Altss estimate) — largely reinsured via a 2019 buy-in, now held as a bulk annuity contract.

Location

Region

Europe

Country

United Kingdom

City

London

Corporate office

London, United Kingdom

Principals

Michael Chatterton

Chairman of the Trustee Board

Sarah Kuijlaars

Chief Financial Officer, Tate & Lyle PLC

Nick Hampton

Chief Executive Officer, Tate & Lyle PLC

Imran Nawaz

Former CFO, Tate & Lyle PLC

Sector focus

Bulk Annuity Insurance

Frequently asked questions

What was the 2019 transaction that reshaped the Tate & Lyle Pension Plan?

In 2019, the plan executed a full buy-in with Legal & General, covering approximately £2.5 billion in pension liabilities. The transaction transfers the plan's longevity, interest-rate, and inflation risk to an insurance counterparty. It was overseen by then-CFO Imran Nawaz and represents a complete derisking of the scheme's obligations.

Who runs investment decisions for the plan today?

Investment discretion is minimal following the 2019 full buy-in. The trustee board, chaired by Michael Chatterton, retains fiduciary oversight, but the majority of assets are now managed by Legal & General under the terms of the bulk annuity contract. Any residual self-managed assets are likely modest and held for near-term liquidity needs.

How does the plan allocate capital after the buy-in?

The plan no longer operates a traditional multi-asset portfolio. Its capital primarily sits within a Legal & General bulk annuity policy, which backs the liabilities with a matching portfolio of high-grade bonds and gilts. The scheme effectively functions as a supervised insurance contract rather than an active allocator.

What is the governance relationship between the plan and Tate & Lyle PLC?

Tate & Lyle PLC is the sponsoring employer, with current CFO Sarah Kuijlaars (appointed September 2024) and CEO Nick Hampton representing the corporate side of the relationship. The trustee board, chaired by Michael Chatterton, operates independently to safeguard member interests, coordinating with corporate leadership on residual funding and governance matters.

Is the plan still open to new members or accruals?

The plan's defined-benefit section is closed to future accrual, consistent with the 2019 derisking and the broader UK trend of corporate defined-benefit scheme closure. The buy-in covers all accrued benefits for existing members and pensioners, with no new liabilities being added.

What residual investment exposure does the plan retain?

Public disclosures suggest the plan retains minimal self-managed exposure outside the buy-in contract, likely limited to short-duration cash and liquidity instruments used for fee payments and final administrative expenses. The plan no longer maintains meaningful equity, credit, or alternative-asset exposures.

Does the scheme still maintain relationships with external fund managers?

Any remaining external manager relationships are likely limited to advisory or small liquidity mandates. The 2019 buy-in consolidated the bulk of asset management inside Legal & General's insurance portfolio. The trustee board may retain investment consultants for ongoing actuarial and governance support as the scheme moves toward eventual buyout.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo